| 507 |
Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 508 |
Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 509 |
Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 510 |
Demethylation of PPAR promotor leading to vascular disrupting effects |
Yanhong Wei |
BY-SA |
228: peroxisome proliferator activated receptor promoter demethylation
|
2161: Increase, Vascular disrupting effects
|
|
|
| 511 |
The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects |
Yanhong Wei |
BY-SA |
1115: Increase, Reactive oxygen species
|
2161: Increase, Vascular disrupting effects
|
|
|
| 512 |
Reduced availability of GnRH leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Ana-Andreea Cioca |
BY-SA |
None
|
None
|
|
|
| 513 |
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 514 |
PLK1 Activation leading to hepatocyte apoptosis-associate liver injury via autophagy-mediated excessive COX6A1 degradation and impaired function of mitochondrial respiratory chain complex IV |
Hui Li |
BY-SA |
None
|
None
|
|
|
| 515 |
An overview of adverse outcome pathway linked between PM2.5 exposure and congenital heart defects |
Liang Chen |
BY-SA |
None
|
None
|
|
|
| 516 |
Na+ /K+ -ATPase inhibition leading to hypertension |
Michelle Angrish |
BY-SA |
1562: Decreased Na/K ATPase activity
|
952: Hypertension
|
|
|
| 517 |
Pregnane X Receptor (PXR) activation leads to liver steatosis |
John Frisch |
BY-SA |
239: Activation, Pregnane-X receptor, NR1I2
|
459: Increase, Liver steatosis
|
|
|
| 518 |
Liver X Receptor (LXR) activation leads to liver steatosis |
John Frisch |
BY-SA |
167: Activation, LXR
|
459: Increase, Liver steatosis
|
|
|
| 478 |
Deposition of energy leading to occurrence of cataracts |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2083: Occurrence of Cataracts
|
WPHA/WNT Endorsed |
1.89 |
| 481 |
AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases. |
Hailin Xu |
BY-SA |
1115: Increase, Reactive oxygen species
|
2 AOs
|
|
|
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 483 |
Deposition of Energy Leading to Learning and Memory Impairment |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.89 |
| 484 |
Bisphenol A analogs induce cellular dysfunction in human trophoblast cells in a thyroid hormone receptor-dependent manner: in silico and in vitro analyses |
Xiaoyun Wu |
BY-SA |
None
|
None
|
|
|
| 485 |
Thyroid hormone antagonism leading to impaired oligodendrocyte maturation during development and subsequent decreased cognition |
Eliska Kuchovska |
BY-SA |
1656: Antagonism, Thyroid Receptor
|
402: Cognitive function, decreased
|
|
|
| 486 |
Binding to the extracellular protein laminin leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
2109: Binding, extracellular matrix protein laminin
|
402: Cognitive function, decreased
|
|
|
| 487 |
Unknown MIE altering cholesterol metabolism leading to decreased cognition |
Eliska Kuchovska |
BY-SA |
1114: Unknown, MIE
|
402: Cognitive function, decreased
|
|
|
| 488 |
Increased reactive oxygen species production leading to decreased cognitive function |
Eliska Kuchovska |
BY-SA |
1115: Increase, Reactive oxygen species
|
402: Cognitive function, decreased
|
|
|
| 489 |
Inhibition of voltage-gated sodium channels leading to decreased cognition |
Lidwina Gerner |
BY-SA |
1353: Binding to voltage-gated sodium channel
|
402: Cognitive function, decreased
|
|
|
| 490 |
Co-activation of IP3R and RyR leads to reduced IQ and increased socio-economic burden through non-cholinergic mechanisms |
Karine Audouze |
BY-SA |
2 MIEs
|
3 AOs
|
|
|
| 492 |
Glutathione conjugation leading to reproductive dysfunction via oxidative stress |
Leonardo Vieira |
BY-SA |
2131: Conjugation, GSH
|
406: decreased, Fertility
|
|
|
| 493 |
ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity |
Min Ji Kim |
BY-SA |
2126: Estrogen receptor alpha inactivation
|
2129: Metabolically unhealthy Obesity
|
|
|